News

 

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine
PCB imagen recurso
Public research at the Barcelona Science Park – UB reaches a record investment of €84 million in 2024
Healthcare
The public research institutes, together with the units and groups of the University of Barcelona (…
Partners - Parc Científic de Barcelona
Imagen recurso de unos pulmones
BCN HEALTH publica un estudio evaluando la incidencia y el coste de la enfermedad renal crónica en España
Healthcare
BCN HEALTH has published in the Journal of Medical Economics a study analyzing the incidence,…
Partners - BCN Health
oryzon
ORYZON announces First‑Patient‑In (FPI) in RESTORE Phase Ib trial of iadademstat in sickle cell disease
Healthcare
Recently approved by the European Medicines Agency, RESTORE will evaluate iadademstat’s ability to…
Partners - Oryzon Genomics
Fachada de las oficinas de Oryzon Genomics
ORYZON to participate in upcoming events in November
Corporate
Oryzon Genomics, S.A., a clinical-stage biopharmaceutical company and global leader in epigenetics…
Partners - Oryzon Genomics
AptaTargets Merck
GENESIS Biomed participated in the strategic development of AptaTargets, which has licensed its drug ApTOLL to Merck
Access to innovation · Financing
AptaTargets signed in May 2025 a licensing agreement with Merck for the clinical development and…
Partners - GENESIS Biomed
Glycobasque event photo
Glycobasque 8 brought together leading international figures in glycosciences in San Sebastián hosted by Asparia Glycomics
Healthcare
The eighth edition of Glycobasque turned San Sebastián into a hub for glycoscience research on…
Partners - ASPARIA GLYCOMICS
Inhibitec
When biotechnology puts itself in the patient’s skin
Healthcare · Access to innovation · Innovative drugs
The biotech company Inhibitec is advancing the development of an antibody targeting the BAMBI…
AseBio - Inhibitec Anticuerpos
Parc Cientific de Barcelona
Public research at the Barcelona Science Park – UB reaches a record investment of €84 million in 2024
Corporate
The public research ecosystem of the Barcelona Science Park (PCB-UB) continues to expand, achieving…
Partners - Parc Científic de Barcelona
Detalle de una planta en un campo de cultivo
Biotechnology emerges as Spain’s key tool against climate change: nearly 600 solutions developed to drive the green transition
Agrifood · Food & feed · Agriculture · Animal health
At AseBio, our Sustainability Commission has prepared the report “Biotechnology Applied to the…